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coloured fluorescent lighting may interfere with the
readings. The protein portion must be held very near to
the protein colour chart to get accurate quantitative
assessment of the degree of proteinuria present.'
Conclusion
Vristix have been found to be a reliable, clean, quick
and excellent method of testing urine for the presence of
glucose and protein substances, in the routine care of
antenatal patients, and in those patients admitted to a
gynaecological ward for surgery. It is rare for Vristix to
miss protein or glucose when these are present in urine.
When these are found, further investigation to assess the
amount and its cause should obviously be undertaken.
False positive results will then be eliminated. The test is
sensitive, the protein portion more 0 to albumins, and the
sugar portion is specific for glucose.
I wish to thank Mr. S. loel Cohen for suggesting the investi-
gation and Sister M. Readhead, the Ames nursing represen-
tative, for full cooperation.
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AN EVALUATION OF CURRENT TRENDS IN PREGNANCY TESTING
c. C. J. GIBBS, Department of Physiology and Pharmacology, UniversiTY of Cape Town
The detection of pregnancy by means of testing a
suspected patient's urine dates from 1928 when Aschheim
and Zondek' described their well-known test in which the
injection of urine from a pregnant woman results in a
precocious full ovarian cycle in immature virgin female
mice. Although the authors did not know so at the time,
this reaction is due to the activity of a gonadotrophic
hormone secreted by the developing chorion, a substance
now called 'human chorionic gonadotropin' (BCG). All
subsequent pregnancy tests, including those most recently
developed, have also depended on the detection of this
substance in the patient's urine.
In subsequent modifications, other experimental animals
(e.g. rabbits,' Xenopus laevis; and rats') and prepared ex-
tracts of the urines were used with a view to increasing
the rapidity and accuracy of the test. Each of these modi-
fications had its own circle of advocates and adherents,
and each carried (whatever its advantages) all the dis-
abilities of a biological procedure. Here at Cape Town
the Xenopus test, using a kaolin-extraction procedure to
concentrate the urinary HCG,' was judged to be the most
efficient when all factors such as reliability, early detec-
tion of pregnancy, technical ease, and expense had been
taken into account.
In 1934 Selye et al."l reported that animals repeatedly
exposed to HCG tend to lose their sensitivity, and this was
soon suggested to be due to the evocation of an immuno-
logical response,' a hypothesis that was subsequently con-
firmed: and that had its practical application in the
recently developed immunological tests for the detection
of HCG in urine. During 1960 several papers were
published describing complement fixation,'· a precipitin
technique," and an agglutination-inhibition technique" as
means of demonstrating the presence or absence of urinary
HCG in a woman suspected of pregnancy. The last-
mentioned test was incorporated in several proprietary
testing kits based on the inhibition of haemagglutination
of sensitized sheep cells* or the inhibition of agglutination
*e.g. Prepuerin, Burroughs Wellcome & Co., London; VCG-
test, Wampole Labs.; Pregnosticon, Organon Inc.; etc.
of sensitized latex particles.** Comparisons of the accu-
racy of the Xenopus test with those of several of these
tests have already been published."'"
These agglutination-inhibition tests represent an advance
on the biological tests for the following reasons:
I. They achieve a high degree of accuracy and sensitivity,
obtainable without taking all the precautions of multiple tests
that a biological method entails.
2. They require a far smaller sample of urine and this does
not necessarily have to be an early morning specimen.
3. They require less time to set up and also yield a result
more quickly.
On the other hand there are several disadvantages:
I. False posilive tests tend to occur in a small percentage
of cases (2 - 4% according to a survey published this year").
2. Equivocal results occur in a further percentage of cases.
3. The tests still require centrifuging and other technical
procedures and are thus outside the province of the average
clinician.
The latest development is a simple and rapid slide-
agglutination testt based on the inhibition of agglutination
of sensitized latex particles by urinary HCG. Th is test
overcomes all the technical difficulties of previous tests
and can easily be done by any clinician as a side-room
procedure, the only requirements being the kit, one drop
of the patient's urine and a little practice in reading slide-
agglutination reactions. The question is whether this test
provides all these advantages without sacrificing accuracy,
and to determine this the following survey was carried out
in the laboratories of the Department of Physiology, VCT.
METHOD
Each of 167 samples of urine submitted to the Department for
routine pregnancy testing was examined by
1. The Xenopus test (as described by Zwarenstein and
Duncan');
2. The Prepuerin test (following the manufacturer's Ill-
structions); and
3. The Gravindex test (following the manufacturer's in-
structions).
**Ortho Pregnancy Test. Orrha Pharmaceutical Corporation. Raritan. '.J.
USA
tGravindex. Ortho Pharmaceutical Corporation, Raritan, N.J., USA.
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The specimens were unselected, and no attempt was made to
follow the patients up clinically since it was merely desired to
ascertain how the results obtained with various tests would
agree and whether the Gravindex test could be accepted as a
reliable routine test for pregnancy. The results are summa-
rized in Table I:
TABLE I. RESULTS OF PREGNANCY TESTING USING 3 METHODS
o.o/cases Xellopus Prepuerill Gravilldex








It will be noticed that in 157 cases (85%) there was complete
agreement.
In 5 cases (3%) the Gravindex test gave a negative result
when the other tests were positive. In 2 of these the patient's
period was less than 7 days overdue and the Gravindex test
was positive when repeated a week later. As the Xenopus
test is known to be unreliable at such an early stage of
pregnancy, the discrepancy must be regarded as fortuitous. In
2 more of these cases the frogs laid very few eggs, thus
suggesting the possibility that these women were either at a
very early stage of pregnancy or secreting a low titre of
hormone for some other cause. In the fifth case the Prepuerin
test, although accepted as positive, gave a somewhat atypical
reaction. These observations might explain why the Gravindex
test was negative, particularly as it is commonly recognized in
the literature to be a less sensitive indicator of very low titres
of HCG than other immunological tests.'·
In 3 cases (1.2%) the Xenopus test gave a false negative
reaction, and in all these cases the Gravindex test proved
reliable.
One each of discrepant positive and negative reactions were
obtained from the Prepuerin test.
DISCUSSION
These results confirm the conclusions previously published
'that the haemagglutination inhibition method is at least
as accurate as the Xenopus laevis test""l4 and show that
the accuracy and sensitivity of the Gravindex test is of
the same order. The biological test detected 5 pregnancies
that the Gravindex test missed, but the Gravindex test
detected 3 positives that the frog test missed. If, however,
the same precaution is followed with the Gravindex test
as is followed with the Xenopus test (viz. asking for a
repeat specimen on all negative cases in 2 weeks time), the
accuracy of the two tests is identical. As there is a
tendency to neglect some of the necessary precautions in
the biological test (e.g. using only 1 frog instead of 4) the
Gravindex test may well turn out to be more accurate in
general laboratory practice.
With this point established, the many advantages of the
Gravindex test become obvious:
I. Only one drop of urine is required instead of a minimum
of 4 ounces.
2. It is not necessary to use an early morning specimen of
urine since random specimens are equally acceptable.
3. A result is available v.ithin 3 minutes-as against 18
hours with the frog and Prepuerin tests.
4. The Gravindex test is considered to be more accurate
than the Prepuerin (and most other haemagglutination
inhibition tests) because
(a) no equivocal results occur, and
(b) false positive reactions are not found (an observa-
tion which is generally supported in the litera-
ture,·,H).
On the basis of this survey the Gravindex test has now
been the routine test for pregnancy diagnosis in this
department since February 1964.
This test introduces a new dimension into pregnancy
testing. It may well be that the testing of urine for HCG
will in time become considered a routine side-room or
office procedure, and except for problem cases be lifted
right out of the sphere of the clinical laboratory with
consequent saving of time to the physician and expense to
the patient. Certainly this simple test has already proved
a great boon to country practitioners.
SUMMARY
An outline of the development of pregnancy testing is
given and a comparison of the results of testing 167
random samples of urine with 3 different tests (the Xeno-
pus test, a haemagglutination-inhibition test, and a slide-
agglutination test) is made. It is concluded that the slide-
agglutination test is as reliable as biological testing and
more efficient when all factors are taken into considera-
tion.
I wish to thank Prof. H. Zwarenstein for guidance and
assistance in carrying out this work and the preparation of this
paper, and Prof. A. W. Sloan for helpful criticism. Grateful ac-
knowledgement is made to the Ortho Pharmaceutical Corpora-
tion and to Messrs. Burroughs Wellcome & Co. for kindly
supplying the material used in the survey.
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